BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18329457)

  • 1. Aprotinin: twenty-five years of claim and counterclaim.
    Westaby S
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):487-91. PubMed ID: 18329457
    [No Abstract]   [Full Text] [Related]  

  • 2. Aprotinin and cardiac surgery.
    DeAnda A
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):492-4. PubMed ID: 18329458
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of aprotinin in Norway.
    Bjella L; Greiff G; Pleym H; Stenseth R; Wahba A
    Acta Anaesthesiol Scand; 2007 Feb; 51(2):261; author reply 261. PubMed ID: 17261150
    [No Abstract]   [Full Text] [Related]  

  • 4. Bleeding in cardiac surgery: the use of aprotinin does not affect survival.
    Pagano D; Howell NJ; Freemantle N; Cunningham D; Bonser RS; Graham TR; Mascaro J; Rooney SJ; Wilson IC; Cramb R; Keogh BE
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):495-502. PubMed ID: 18329459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aprotinine: safe use in surgical practice].
    Dement'eva II; Charnaia MA; Morozov IuA
    Anesteziol Reanimatol; 2007; (2):69-71. PubMed ID: 17564008
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized study of aprotinin effect on transfusions and blood loss in primary THA.
    Colwell CW; Chelly JE; Murkin JM; Stevens D; O'Keefe TJ; Hall R; Parvizi J
    Clin Orthop Relat Res; 2007 Dec; 465():189-95. PubMed ID: 17767075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of recombinant activated factor VII in major thoracic operations.
    Alavi AA; Jalali SM; Rasouli MR; Eghtesadi-Araghi P
    Arch Surg; 2008 Oct; 143(10):1021; author reply 1021. PubMed ID: 18936387
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aprotinin -- an allogeneic transfusion sparing drug].
    Haas S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):38-40. PubMed ID: 12522728
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylactic drug treatment in the prevention of postoperative bleeding.
    Tyers GF
    Ann Thorac Surg; 1997 Mar; 63(3):912. PubMed ID: 9066438
    [No Abstract]   [Full Text] [Related]  

  • 10. Current methods to reduce the adverse haematological consequences of cardiopulmonary bypass.
    John LC; Deverall PB
    Br J Clin Pract; 1996 Jun; 50(4):203-6. PubMed ID: 8759566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Liver transplantation: the problem of peroperative bleeding].
    Roseau E
    Presse Med; 2000 Jul; 29(23):1289-90. PubMed ID: 10923137
    [No Abstract]   [Full Text] [Related]  

  • 12. Reducing allogeneic transfusion in cardiac surgery.
    Tempe DK
    Br J Anaesth; 2005 Aug; 95(2):277-8. PubMed ID: 16006659
    [No Abstract]   [Full Text] [Related]  

  • 13. ICVTS on-line discussion A Plateletpheresis or aprotinin, which is the key element?
    Kan CD
    Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):622; discussion 622. PubMed ID: 17884856
    [No Abstract]   [Full Text] [Related]  

  • 14. Invited commentary.
    Hoch JR
    J Vasc Surg; 2011 Apr; 53(4):1037-8. PubMed ID: 21439457
    [No Abstract]   [Full Text] [Related]  

  • 15. [Administration of aprotinin in surgical interventions associated with a high risk hemorrhagic complications].
    Charnaia MA; Dement'eva II
    Khirurgiia (Mosk); 2005; (11):71-6. PubMed ID: 16358454
    [No Abstract]   [Full Text] [Related]  

  • 16. Thromboelastographic analysis of patients receiving aprotinin with comparisons to platelet aggregation and other assays.
    Koza MJ; Walenga JM; Khenkina YN; Sullivan HJ; Montoya A; Pifarre R
    Semin Thromb Hemost; 1995; 21 Suppl 4():80-5. PubMed ID: 8747694
    [No Abstract]   [Full Text] [Related]  

  • 17. Aprotinin's effect on blood product transfusion in off-pump bilateral lung transplantation.
    Balsara KR; Morozowich ST; Lin SS; Davis RD; Phillips-Bute BG; Hartwig M; Appel JZ; Welsby IJ
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):45-8. PubMed ID: 18669527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
    Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward reducing perioperative transfusions.
    Joyce JA
    AANA J; 2008 Apr; 76(2):131-7. PubMed ID: 18478819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
    Body SC; Mazer CD
    Anesth Analg; 2006 Dec; 103(6):1354-9. PubMed ID: 17122202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.